We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Diagnostic value of MDM2 RNA in situ hybridization for low-grade osteosarcoma: Consistency comparison of RNA in situ hybridization, fluorescence in situ hybridization, and immunohistochemistry

    Detection of MDM2 gene amplification via fluorescence in situ hybridization (FISH) and MDM2 overexpression by immunohistochemistry (IHC) have been...

    Chen Chen, **n He, ... Hongying Zhang in Virchows Archiv
    Article 28 March 2023
  2. Immunoglobulin light chain transcript detection by ultrasensitive RNA in situ hybridization for B-cell lymphoma diagnosis

    Evaluation of B-cell clonality can be challenging in the interpretation of lymphoid infiltrates on tissue sections. Clonality testing based on IG ...

    Luisa Lorenzi, Silvia Lonardi, ... Fabio Facchetti in Virchows Archiv
    Article 26 October 2023
  3. Fluorescent in situ hybridization has limitations in screening NRG1 gene rearrangements

    Background

    NRG1 fusion is a promising therapeutic target for various tumors but its prevalence is extremely low, and there are no standardized testing...

    **aomei Zhang, Lin Li, ... Qing Ye in Diagnostic Pathology
    Article Open access 03 January 2024
  4. HPV-Associated Squamous Cell Carcinoma of the Eyelid: Diagnostic Utility of p16 Immunohistochemistry and mRNA In Situ Hybridization

    Background

    High-risk (HR) Human papillomavirus (HPV) has been implicated in pathogenesis of squamous cell carcinomas (SCC) at several sites with...

    Aanchal Kakkar, Kirti Srivastava, ... Suryanarayan V. S. Deo in Head and Neck Pathology
    Article 21 September 2023
  5. Clinical application of the HM-1000 image processing for HER2 fluorescence in situ hybridization signal quantification in breast cancer

    Background

    Accurate quantification of human epidermal growth factor receptor 2 ( HER2 ) gene amplification is important for predicting treatment...

    Vicente Peg, Teresa Moline, ... Santiago Ramon y Cajal in Diagnostic Pathology
    Article Open access 15 February 2024
  6. Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS)

    Alveolar soft-part sarcoma (ASPS) is a rare soft tissue tumor with a broad morphologic differential diagnosis. While histology and...

    Alexander S. Taylor, Rahul Mannan, ... Rohit Mehra in Medical Oncology
    Article Open access 23 February 2024
  7. A Novel Scoring System for MYB RNA In Situ Hybridization Displays High Sensitivity and Specificity for Adenoid Cystic Carcinoma in a Clinical Setting

    Background

    MYB RNA in situ hybridization (ISH) has emerged as a reliable and accessible marker to support adenoid cystic carcinoma (ACC) diagnosis,...

    Mariel Bedell, Dale W. Lewis, Raja R. Seethala in Head and Neck Pathology
    Article 19 June 2024
  8. An in situ hybridization study of syndecan family during the late stages of develo** mouse molar tooth germ

    Expression of syndecan - 1, 2, 3 , and 4 mRNAs during the late stages of tooth germ formation was investigated by in situ hybridization, using [ 35 S]-UTP-...

    Kaoru Fujikawa, Naoko Nonaka, ... Shunichi Shibata in Anatomical Science International
    Article 04 February 2022
  9. Diagnosis of Adenoid Cystic Carcinoma with Striking Tubular Hypereosinophilia by MYB and EWSR1 Breakapart Fluorescence In Situ Hybridization

    Background

    Adenoid cystic carcinoma (AdCC), associated with MYB/MYBL1 gene rearrangements, shows epithelial and basaloid myoepithelial cells arranged...

    Urvashi Yadav, Ria Mahendru, ... Aanchal Kakkar in Head and Neck Pathology
    Article 27 November 2023
  10. CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization

    Introduction

    CDKN2A/B homozygous deletion is one of the defining features of grade 4 in IDH -mutant astrocytic tumours.

    Aim

    To evaluate CDKN2A/B- deleti...

    Manali Ranade, Sridhar Epari, ... Tejpal Gupta in Journal of Neuro-Oncology
    Article 24 January 2024
  11. HER2 copy number determination in breast cancer using the highly sensitive droplet digital PCR method

    Human epidermal growth factor receptor 2 (HER)-positive breast cancer (BC) is characterized by an aggressive clinical course. In the case of HER2...

    Beate Alinger-Scharinger, Cornelia Kronberger, ... Heidi Jaksch-Bogensperger in Virchows Archiv
    Article Open access 23 November 2023
  12. A new diagnostic algorithm using biopsy specimens in adult T-cell leukemia/lymphoma: combination of RNA in situ hybridization and quantitative PCR for HTLV-1

    Histopathological distinction between adult T-cell leukemia/lymphoma (ATLL) and other T-cell neoplasms is often challenging. The current gold...

    Mitsuyoshi Takatori, Shugo Sakihama, ... Kennosuke Karube in Modern Pathology
    Article Open access 17 August 2020
  13. PDGFB RNA in situ hybridization for the diagnosis of dermatofibrosarcoma protuberans

    Dermatofibrosarcoma protuberans (DFSP) is a spindle cell neoplasm of the skin and superficial soft tissue with a tendency for locally aggressive...

    Jeffrey M. Cloutier, Grace Allard, ... Gregory W. Charville in Modern Pathology
    Article 24 March 2021
  14. Impact of HER2-low status for patients with early-stage breast cancer and non-pCR after neoadjuvant chemotherapy: a National Cancer Database Analysis

    Purpose

    To investigate potential differences in pathological complete response (pCR) rates and overall survival (OS) between HER2-low and HER2-zero...

    Huiyue Li, Jennifer K. Plichta, ... Sheng Luo in Breast Cancer Research and Treatment
    Article 08 December 2023
  15. Unusual split green-orange signals in USP6 fluorescence in situ hybridization in a malignant peripheral nerve sheath tumor with a novel NF1-SCIMP fusion: a potential diagnostic pitfall

    Deletion of the neurofibromatosis 1 ( NF1 ) gene is common, but NF1 rearrangement or fusion has rarely been reported in peripheral nerve sheath tumors....

    Yan Qiu, Wenyi **g, ... Hongying Zhang in Virchows Archiv
    Article 19 August 2021
  16. Nodal pCR and overall survival following neoadjuvant chemotherapy for node positive ER+/Her2- breast cancer

    Purpose

    The role of neoadjuvant chemotherapy (NAC) in node-positive (N+) ER+/HER2- breast cancer (BC) is debated, given low total pathologic complete...

    Dan Moldoveanu, Tanya L. Hoskin, ... Judy C. Boughey in Breast Cancer Research and Treatment
    Article 25 October 2023
  17. Variable levels of spike and ORF1ab RNA in post-mortem lung samples of SARS-CoV-2-positive subjects: comparison between ISH and RT-PCR

    Post-mortem examination plays a pivotal role in understanding the pathobiology of the SARS-CoV-2; thus, the optimization of virus detection on the...

    Federica Zito Marino, Tiziana De Cristofaro, ... Renato Franco in Virchows Archiv
    Article Open access 01 February 2022
  18. Correlating SS18-SSX immunohistochemistry (IHC) with SS18 fluorescent in situ hybridization (FISH) in synovial sarcomas: a study of 36 cases

    The recently introduced, highly sensitive and specific SS18-SSX immunohistochemistry (IHC) is an attractive alternative to SS18 fluorescence in situ...

    Timothy Kwang Yong Tay, Nadiah Binte Sukma, ... Kenneth Tou En Chang in Virchows Archiv
    Article 05 June 2021
  19. Accuracy of HPV E6/E7 mRNA examination using in situ hybridization in diagnosing cervical intraepithelial lesions

    Background

    The consistency of pathologists in the diagnosis of cervical intraepithelial neoplasia (CINs) is not ideal, especially between low- and...

    Chang Hui, Huimin Bai, ... Yuzhen Liu in Diagnostic Pathology
    Article Open access 19 February 2021
  20. Clinical significance of quantitative categorization of HER2 fluorescent in situ hybridization results in invasive breast cancer patients treated with HER2-targeted agents

    HER2 ( ERBB2 ) gene status serves as a strong predictive marker of response to HER2-targeted agents in invasive breast cancers, albeit with...

    Mohamed Alhamar, Bassam Alkamachi, ... Dhananjay A. Chitale in Modern Pathology
    Article 21 January 2021
Did you find what you were looking for? Share feedback.